ADC Therapeutics S.A.
ADC Therapeutics S.A.（ADCT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
adct · 股价预测 · 12 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 12 位华尔街分析师
Buy
12 位分析师
共识
评级分布
12 个月目标价
High
$5.00
Consensus
$3.50
+239.8% upside
Low
$2.00
Median: $3.5 · Last Close: $1.03
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$3.50
239.8% upside
High Target
$5
385.4%
Low Target
$2
94.2%
Current Price
$1.03
as of today
Based on analyst price targets, the ADCT stock price prediction for the next 12 months ranges from $2 to $5. The consensus ADCT price forecast of $3.50 implies 239.8% upside from the current price of $1.03.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.03 | ↑ 0.00% |
1-day model range: $0.99–$1.07. Peak: $1.07 (+0.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ADCT · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-04 | RBC Capital | Downgrade ↓ | Outperform→Sector Perform |
| 2026-05-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-05 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-03-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-13 | Guggenheim | Maintains | Buy→Buy |
| 2025-06-20 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-06-13 | Guggenheim | Maintains | Buy→Buy |
| 2025-05-15 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-03-31 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on ADC Therapeutics S.A. (ADCT) stock. Of the recent 70 rating actions, 1 were upgrades and 5 were downgrades. 12 analysts currently cover ADCT.
分析师推荐趋势
ADCT analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$81M
↓ 65.0% YoY
Revenue Next Year
$125M
↑ 53.5% YoY
EPS This Year
$-0.84
EPS Next Year
$-0.65
↓ 23.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ADCT EPS of $-0.84 for the current fiscal year, based on estimates from 4 analysts. The ADCT revenue forecast is $81M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ADCT 股价预测由两类独立数据源支撑：来自 12 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ADCT 的共识目标价为 $3.50（+239.8% 上行空间），分析师共识为 Buy。
ADCT 的短期预测（明日）为 $1.03（+0.00%）。
ADC Therapeutics S.A. 在 NYSE 上市，代码 ADCT。ADCT 在 2027 年的整体展望偏积极，在覆盖分析师中约 50% 对应 Buy 共识。
常见问题
ADCT 预测 · 8 个问题根据 12 位华尔街分析师，ADCT 的 12 个月平均目标价为 $3.50，最高 $5.00、最低 $2.00。若有图表，中位目标价可在上方查看。相对当前价 $1.03，隐含约 +239.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.